Results 251 to 260 of about 8,024,802 (308)
Some of the next articles are maybe not open access.
Stereotactic body radiation therapy for oligometastases
Expert Review of Anticancer Therapy, 2009The standard treatment for metastatic cancer is systemic therapy. However, in a subset of patients with limited extracranial metastases or oligometastases, local ablative therapy in combination with systemic therapy may improve treatment outcomes.
Simon S, Lo +11 more
openaire +2 more sources
Practical Radiation Oncology, 2022
PURPOSE This updated report on stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) is part of a series of consensus-based white papers previously published addressing patient safety. Since the first white papers were published,
I. Das +8 more
semanticscholar +1 more source
PURPOSE This updated report on stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) is part of a series of consensus-based white papers previously published addressing patient safety. Since the first white papers were published,
I. Das +8 more
semanticscholar +1 more source
International Journal of Radiation Oncology, Biology, Physics, 2021
PURPOSE We sought to investigate the tumor control probability (TCP) of spinal metastases treated with stereotactic body radiation therapy (SBRT) in 1 to 5 fractions.
S. Soltys +15 more
semanticscholar +1 more source
PURPOSE We sought to investigate the tumor control probability (TCP) of spinal metastases treated with stereotactic body radiation therapy (SBRT) in 1 to 5 fractions.
S. Soltys +15 more
semanticscholar +1 more source
International Journal of Radiation Oncology, Biology, Physics, 2022
489 Background: To determine if SBRT followed by sorafenib (SBRT/S) improves overall survival (OS), progression free survival (PFS) and quality of life (QOL) vs. sorafenib alone (S), in patients (pts) with HCC.
L. Dawson +19 more
semanticscholar +1 more source
489 Background: To determine if SBRT followed by sorafenib (SBRT/S) improves overall survival (OS), progression free survival (PFS) and quality of life (QOL) vs. sorafenib alone (S), in patients (pts) with HCC.
L. Dawson +19 more
semanticscholar +1 more source
Stereotactic Body Radiation Therapy
2015Stereotactic body radiotherapy (SBRT) is a noninvasive method to deliver high doses of precision radiotherapy to small tumors in the body using novel technologies developed over the last 15 years. Since its inception, this approach was initially developed to shorten therapy for patients with severe limitations making more prolonged courses of radiation
Steven J. Feigenberg +5 more
openaire +2 more sources
[Stereotactic body radiation therapy and oligometastases].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2014In stage IV cancers, locoregional management of primitive tumours as surgery and/or radiotherapy improved both progression-free survival and overall survival. Among metastatic cancer patients, some of them are considered as oligometastatic stage as they present few metastatic sites associated with low tumor aggressiveness.
Bourgier, Céline +7 more
openaire +2 more sources
International Journal of Radiation Oncology, Biology, Physics, 2019
PURPOSE To review the radiobiological mechanisms of stereotactic body radiation therapy stereotactic body radiation therapy (SBRT) and stereotactic radiation surgery (SRS).
C. Song +9 more
semanticscholar +1 more source
PURPOSE To review the radiobiological mechanisms of stereotactic body radiation therapy stereotactic body radiation therapy (SBRT) and stereotactic radiation surgery (SRS).
C. Song +9 more
semanticscholar +1 more source
Emergence of Stereotactic Body Radiation Therapy
Oncology Nursing Forum, 2014Stereotactic body radiation therapy (SBRT) evolved from the application of stereotactic radiosurgery, which is focused intracranial radiation. SBRT offers high doses of specific radiation with oligofractions (five or less) to a specified target, providing local control to circumscribed tumors while sparing surrounding normal tissue.
openaire +2 more sources
International Journal of Radiation Oncology, Biology, Physics, 2021
PURPOSE/OBJECTIVES Pancreatic stereotactic body radiation therapy (SBRT) is limited to gross tumor without elective coverage for subclinical disease. Given a better understanding of recurrence patterns, we hypothesized that the addition of elective nodal
Jacob A. Miller +6 more
semanticscholar +1 more source
PURPOSE/OBJECTIVES Pancreatic stereotactic body radiation therapy (SBRT) is limited to gross tumor without elective coverage for subclinical disease. Given a better understanding of recurrence patterns, we hypothesized that the addition of elective nodal
Jacob A. Miller +6 more
semanticscholar +1 more source
Safety Considerations in Stereotactic Body Radiation Therapy
Seminars in Radiation Oncology, 2017Although many error pathways are common to both stereotactic body radiation therapy (SBRT) and conventional radiation therapy, SBRT presents a special set of challenges including short treatment courses and high-doses, an enhanced reliance on imaging, technical challenges associated with commissioning, special resource requirements for staff and ...
Eric, Ford, Sonja, Dieterich
openaire +2 more sources

